WGS with RNA Sequencing
Baylor Genetics experts Dr. Christine Eng, CMO, CQO, and Dr. Xiaonan Zhao, Associate Clinical Director, discuss the transformative role of RNAseq with WES/WGS in complex and rare disease diagnostics.
Key Highlights:
- The evolution and significance of RNAseq in clinical settings
- Comprehensive testing processes and criteria for variant
eligibility at Baylor Genetics - How RNAseq has been utilized to clarify variants identified through WES/WGS
Please complete the form to access this exclusive content